Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PRAD | rs1110661 | chr22:18444734 | C/T | 3.58E-6 | 494 | 30.8 | 31.87 | 26.37 | KM Plot |
PRAD | rs1110662 | chr22:18444908 | G/A | 3.96E-6 | 494 | 30.8 | 31.87 | 26.37 | KM Plot |
PRAD | rs1110666 | chr22:18457720 | A/C | 3.33E-6 | 494 | 27.83 | 31.43 | 30.8 | KM Plot |
PRAD | rs11107785 | chr12:95305572 | G/T | 4.42E-6 | 493 | 30.97 | 31.23 | 19.2 | KM Plot |
PRAD | rs11111876 | chr12:104417713 | C/A | 1.15E-5 | 489 | 30.78 | 32.25 | 24.27 | KM Plot |
PRAD | rs111319721 | chr7:135060228 | T/TACAC | 3.69E-10 | 485 | 30.8 | 31.33 | 2.33 | KM Plot |
PRAD | rs1113272 | chr4:165646778 | C/T | 5.97E-5 | 490 | 30.75 | 32.15 | 44.32 | KM Plot |
PRAD | rs1113273 | chr4:165646684 | G/A | 5.68E-5 | 492 | 30.77 | 32.9 | 44.32 | KM Plot |
PRAD | rs11136254 | chr8:145158503 | G/T | 1.69E-5 | 482 | 19.1 | 30.57 | 31.13 | KM Plot |
PRAD | rs11136359 | chr8:1152506 | A/T | 3.21E-6 | 494 | 20.75 | 28.93 | 31.27 | KM Plot |
PRAD | rs111427975 | chr11:4100351 | C/T | 0.000126 | 489 | 31.27 | 29.98 | 28.73 | KM Plot |
PRAD | rs111452679 | chr1:1160163 | G/A | 3.05E-10 | 481 | 31.27 | 30.98 | 13.73 | KM Plot |
PRAD | rs111456336 | chr4:187812434 | T/C | 2.18E-6 | 481 | 31.23 | 28.3 | 26.8 | KM Plot |
PRAD | rs11150805 | chr17:79638805 | C/T | 6.14E-5 | 489 | 30.48 | 31.37 | 25.17 | KM Plot |
PRAD | rs111514504 | chr11:54796787 | C/T | 0 | 479 | 31.3 | 28.05 | 17.2 | KM Plot |